Federal agencies have handed out a slew of contracts and contract extensions in recent weeks, including about $370 million in deals for medical supplies and devices.
The biggest takers were Becton Dickinson & Co. (NYSE:BDX), Johnson & Johnson (NYSE:JNJ) and Synthes, who together claimed more than half of the contract funding.
Becton landed a Defense Logistics Agency contract modification worth up to $76.8 million for "various medical and surgical products." The extension is the 2nd year of a contract with up to 7 possible 1-year options to supply products to the Army, Navy, Air Force, Marine Corps, and federal civilian agencies.
Johnson & Johnson won 2 separate DLA contracts worth a total of $63.7 million, one for its Ethicon subsidiary and the other for Ethicon-Endo. The 1st is worth up to $42.1 million , marking the 5th year of a potential 7-year deal. The 2nd, worth up to $21.6 million, is the 4th optional year of a contract extending up to 7 years.
Synthes’ deal, worth up to $50.5 million, extends the 6th year in a 7-year-option contract with the DLA, also pertaining to unspecified medical and surgical products for a range of military and civilian agencies.
More deals:
- Zoll lands $30.5 million DLA contract extension for "airworthy" hospital defibrillators
- Abbott wins $45.3 million DLA contract extension for various medical and surgical products
- Zimmer’s 1st-year DLA contract worth up to $36.9 million
- DePuy wins 2nd year fed contract with up to $18.9 million
- Novartis lands $13.2 million "technology investment" for proactive diagnostics initiative
- Dentsply awarded $31.2 million 2nd-year contract option for dental supplies
- Banyan Biomarkers wins $13 million multi-year contract for brain injury assay for use on J&J diagnostic system
- Myelotec joins Dept. of Veterans Affairs’ Federal Supply Schedule
